Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

293.74
Delayed Data
As of May 25
 -0.87 / -0.30%
Today’s Change
281.89
Today|||52-Week Range
543.55
-21.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
AssetsCash744.3M792.1M812.7M1.0B
 
 
 
 
 
Short Term Investment Cash-67.5M47.8M20.7M206.8M
 
 
 
 
 
Cash & Short Term Investments1.3B1.4B1.4B1.6B
 
 
 
 
 
 
ReceivablesReceivables1.8B2.0B2.0B1.9B
 
 
 
 
 
 
InventoriesInventories554.3M641.6M726.1M820.4M
 
 
 
 
 
 
Current AssetsOther Current Assets193.3M143.8M225.0M155.5M
 
 
 
 
 
Current Assets3.9B4.1B4.3B4.5B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross----2.9B--
 
 
Depreciation-----566.3M--
 
 
Other Assets37.0M36.6M77.9M79.0M
 
 
 
 
 
Total Assets8.1B8.7B8.8B9.4B
 
 
 
 
 
 
LiabilitiesAccounts Payable151.4M153.9M178.2M207.6M
 
 
 
 
 
Accrued Expenses395.3M371.8M444.8M666.2M
 
 
 
 
 
Other Current Liabilities708.0M692.0M765.2M1.1B
 
 
 
 
 
Other Liabilities1.0B1.1B1.1B1.3B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt701.2M702.3M703.5M704.6M
 
 
 
 
 
Deferred Taxes-883.0M-927.0M-506.3M-532.3M
 
 
 
 
 
Other Liabilities115.9M125.2M152.1M169.9M
 
 
 
 
 
Total Liabilities2.6B2.6B2.6B2.8B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity5.5B6.1B6.1B6.6B
 
 
 
 
 
Total Shareholder Equity5.5B6.1B6.1B6.6B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding107.1M107.4M107.6M107.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.